BrainStorm Cell Therapeutics
BCLI
#10401
Rank
ยฃ5.02 M
Marketcap
ยฃ0.45
Share price
0.83%
Change (1 day)
-63.29%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2025 (TTM): -ยฃ8.73 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -ยฃ8.74 Million, an increase over its 2023 earnings that were of -ยฃ12.93 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ8.73 Million-0.18%
2024 -ยฃ8.74 Million-32.39%
2023 -ยฃ12.93 Million-29.18%
2022 -ยฃ18.26 Million-0.74%
2021 -ยฃ18.4 Million-23.12%
2020 -ยฃ23.93 Million36.8%
2019 -ยฃ17.49 Million66.71%
2018 -ยฃ10.49 Million181.66%
2017 -ยฃ3.73 Million-0.6%
2016 -ยฃ3.75 Million-41.31%
2015 -ยฃ6.39 Million-8.22%
2014 -ยฃ6.96 Million89.74%
2013 -ยฃ3.67 Million42.27%
2012 -ยฃ2.58 Million-12.45%
2011 -ยฃ2.95 Million63.04%
2010 -ยฃ1.81 Million35.52%
2009 -ยฃ1.34 Million-48.99%
2008 -ยฃ2.62 Million-44.39%
2007 -ยฃ4.7 Million
2005 -ยฃ2.44 Million-91.44%
2004 -ยฃ28.41 Million94007.62%
2003 -ยฃ0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
ยฃ7.43 B-86,455.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-ยฃ0.57 Billion 6,468.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-ยฃ0.6 Billion 6,805.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ1.43 B-16,731.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
ยฃ15.53 M-280.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-ยฃ0.2 Billion 2,131.73%๐Ÿ‡บ๐Ÿ‡ธ USA